Development and Characterization of Controlled Release Mucoadhesive Tablets of Captopril to Increase the Residence Time in the Gastrointestinal Tract

被引:0
|
作者
Dalvadi, Hitesh P. [1 ]
Patel, Jayavdan K. [2 ]
Rajput, Ganesh C. [2 ]
Muruganantham, V. [3 ]
Jayakar, B. [3 ]
机构
[1] CK Pithawalla Inst Pharmaceut Sci & Res, Surat 395007, India
[2] Nootan Pharm Coll, Visnagar, Gujarat, India
[3] Vinayaka Missions Coll Pharm, Salem 636008, Tamil Nadu, India
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2011年 / 30卷 / 02期
关键词
Captopril; Gastro-retentive tablet; Mucoadhesive tablets; Swelling index; CONTROLLED DRUG-DELIVERY; SUSTAINED-RELEASE; BIOADHESIVE POLYMERS; GASTRIC RESIDENCE; SYSTEMS; OPTIMIZATION; FORMULATION; DESIGN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present investigation concerns the development of mucoadhesive tablets of captopril which were designed to prolong the gastric residence time after oral administration. Matrix tablets of captopril were formulated using different mucoadhesive polymers such as guar gum, xanthan gum, hydroxyl propyl methyl cellulose (HPMC) K4M and K15M in various ratios. The tablets were evaluated for physical properties, content uniformity, swelling index, bioadhesive strength and in vitro drug release. Swelling was increased as the concentration and viscosity of HPMC increases. Tablets formulated using guar gum and xanthan gum alone were eroded faster and dissolved completely within 5-7 h, while tablet containing HPMC remain intact and provided slow release up to 11-12 h. It was evident from the study that the formulation F10 containing HPMC K15M and xanthan gum (1:1) exhibited maximum bioadhesive strength of 31.59 +/- 0.05 gm and in vitro drug release was found to be 91.85 % at the end of 12 h with non-fickian diffusion mechanism. The stability studies of optimized batch showed that there was no change in bioadhesive strength and in vitro release when stored at different temperature condition for 90 days. It was concluded that formulation F10 shows the better bioadhesive strength and drug release.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 50 条
  • [31] In vivo determination of the time and location of mucoadhesive drug delivery systems disintegration in the gastrointestinal tract
    Kremser, Christian
    Albrecht, Karin
    Greindl, Melanie
    Wolf, Christian
    Debbage, Paul
    Bernkop-Schnuerch, Andreas
    MAGNETIC RESONANCE IMAGING, 2008, 26 (05) : 638 - 643
  • [32] Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets
    Giordani, Barbara
    Melgoza, Luz Maria
    Parolin, Carola
    Foschi, Claudio
    Marangoni, Antonella
    Abruzzo, Angela
    Dalena, Francesco
    Cerchiara, Teresa
    Bigucci, Federica
    Luppi, Barbara
    Vitali, Beatrice
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 550 (1-2) : 455 - 462
  • [33] Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
    Cazorla-Luna, Raul
    Notario-Perez, Fernando
    Martin-Illana, Araceli
    Ruiz-Caro, Roberto
    Tamayo, Aitana
    Rubio, Juan
    Dolores Veiga, Maria
    PHARMACEUTICS, 2019, 11 (01):
  • [34] Formulation and in vitro evaluation of mucoadhesive controlled release matrix tablets of flurbiprofen using response surface methodology
    Khalid, Ikrima
    Ahmad, Mahmood
    Minhas, Muhammad Usman
    Sohail, Muhammad
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 50 (03) : 493 - 504
  • [35] Formulation Development and Characterization of Controlled Release Core-in-cup Matrix Tablets of Venlafaxine HCl
    Maddiboyina, Balaji
    Jhawat, Vikas
    Sivaraman, Gandhi
    Sunnapu, Omprakash
    Nakkala, Ramya Krishna
    Naik, Mudavath Hanuma
    Gulia, Monika
    CURRENT DRUG THERAPY, 2020, 15 (05) : 503 - 511
  • [36] Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex
    Musuc, Adina Magdalena
    Anuta, Valentina
    Atkinson, Irina
    Popa, Vlad Tudor
    Sarbu, Iulian
    Mircioiu, Constantin
    Abdalrb, Ghaleb Abdalameer
    Mitu, Mirela Adriana
    Ozon, Emma Adriana
    PHARMACEUTICS, 2020, 12 (08) : 1 - 18
  • [37] Physicochemical, pharmacokinetic, and pharmacodynamic characterization of isradipine tablets for controlled release
    Venkatesh, D. N.
    Meyyanathan, S. N.
    Shanmugam, R.
    Kamatham, S. S.
    Campos, J. R.
    Dias-Ferreira, J.
    Sanchez-Lopez, E.
    Cardoso, J. C.
    Severino, P.
    Souto, E. B.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2021, 26 (01) : 92 - 100
  • [38] Modification of the Biorelevant Release Testing of Esophageal Applied Mucoadhesive Films and Development of Formulation Strategies to Increase the Mucosal Contact Time
    Brokmann, Friederike
    Simonek, Paul
    Rosenbaum, Christoph
    PHARMACEUTICS, 2024, 16 (08)
  • [39] ABSENCE OF GASTROINTESTINAL BLEEDING WITH CONTROLLED-RELEASE POTASSIUM-CHLORIDE TABLETS
    MAGGIOCAVALIERE, MB
    DUKSTEIN, WG
    ARNOLD, JD
    BERGER, AE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 16 (04) : 685 - 690
  • [40] Development and characterization of new functionalized polyurethanes for sustained and site -specific drug release in the gastrointestinal tract
    Dolores Campinez, Maria
    Benito, Elena
    Romero-Azogil, Lucia
    Aguilar-de-Leyva, Angela
    de Gracia Garcia-Martin, Maria
    Antonio Galbis, Juan
    Caraballo, Isidoro
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 100 : 285 - 295